Literature DB >> 22433668

Type 2 diabetes and cognitive impairment: linking mechanisms.

José A Luchsinger1.   

Abstract

This manuscript provides a brief review of current concepts in the mechanisms potentially linking type-2-diabetes (T2D) with cognitive impairment. Existing epidemiologic studies, imaging studies, autopsy studies, and clinical trials provide insights into the mechanisms linking T2D and cognitive impairment. There seems to be little dispute that T2D can cause cerebrovascular disease and thus cause vascular cognitive impairment (VCI). Whether T2D can cause late onset Alzheimer's disease (LOAD) remains to be elucidated. Many epidemiologic studies show an association between T2D and cognitive impairment, but the association with VCI seems to be stronger compared to LOAD, suggesting that cerebrovascular disease may be the main mechanism linking T2D and cognitive impairment. Imaging studies show an association between T2D and imaging markers of LOAD, but these observations could still be explained by cerebrovascular mechanisms. Autopsy studies are few and conflicting, with some suggesting a predominantly cerebrovascular mechanism, and others providing support for a neurodegenerative mechanism. Thus far, the evidence from clinical trials is mixed in supporting a causal association between T2D and cognitive impairment, and most clinical trials that can answer this question are yet to be reported or finished. Given the epidemic of T2D in the world, it is important to elucidate whether the association between T2D and cognitive impairment, particularly LOAD, is causal, and if so, what the mechanisms are.

Entities:  

Keywords:  Type 2 diabetes; dementia; late onset Alzheimer’s disease; mechanisms; vascular cognitive impairment

Mesh:

Year:  2012        PMID: 22433668      PMCID: PMC3372666          DOI: 10.3233/JAD-2012-111433

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  126 in total

Review 1.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

Review 2.  Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.

Authors:  Vincenza Frisardi; Vincenzo Solfrizzi; Davide Seripa; Cristiano Capurso; Andrea Santamato; Daniele Sancarlo; Gianluigi Vendemiale; Alberto Pilotto; Francesco Panza
Journal:  Ageing Res Rev       Date:  2010-05-02       Impact factor: 10.895

3.  Improved diabetes control in the elderly delays global cognitive decline.

Authors:  J A Luchsinger; W Palmas; J A Teresi; S Silver; J Kong; J P Eimicke; R S Weinstock; S Shea
Journal:  J Nutr Health Aging       Date:  2011-06       Impact factor: 4.075

4.  The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

Authors:  Trevor J Orchard; Marinella Temprosa; Ronald Goldberg; Steven Haffner; Robert Ratner; Santica Marcovina; Sarah Fowler
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

5.  Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

Authors:  Vicki Thallas-Bonke; Carsten Lindschau; Bishoy Rizkalla; Leon A Bach; Geoffrey Boner; Matthias Meier; Hermann Haller; Mark E Cooper; Josephine M Forbes
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

6.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

7.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

8.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

9.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

10.  Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study.

Authors:  Seung-Han Suk; Ralph L Sacco; Bernadette Boden-Albala; Jian F Cheun; John G Pittman; Mitchell S Elkind; Myunghee C Paik
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

View more
  62 in total

1.  Racial-ethnic disparities in the association between risk factors and diabetes: The Northern Manhattan Study.

Authors:  Erin R Kulick; Yeseon P Moon; Ken Cheung; Joshua Z Willey; Ralph L Sacco; Mitchell S V Elkind
Journal:  Prev Med       Date:  2015-12-04       Impact factor: 4.018

2.  Does Low Subjective Social Status Predict Cognitive Decline in Chinese Older Adults? A 4-Year Longitudinal Study From Hong Kong.

Authors:  Jean H Kim; Timothy S Sumerlin; William B Goggins; Elizabeth M S Kwong; Jason Leung; Blanche Yu; Timothy C Y Kwok
Journal:  Am J Geriatr Psychiatry       Date:  2021-01-23       Impact factor: 4.105

3.  Nod-like receptor protein 1 inflammasome mediates neuron injury under high glucose.

Authors:  Xian-Fang Meng; Xiao-Lan Wang; Xiu-Juan Tian; Zhi-Hua Yang; Guang-Pin Chu; Jing Zhang; Man Li; Jing Shi; Chun Zhang
Journal:  Mol Neurobiol       Date:  2013-09-08       Impact factor: 5.590

4.  Amylin: what might be its role in Alzheimer's disease and how could this affect therapy?

Authors:  Florin Despa; Charles Decarli
Journal:  Expert Rev Proteomics       Date:  2013-10       Impact factor: 3.940

5.  The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.

Authors:  Lior Greenbaum; Ramit Ravona Springer; Michael W Lutz; Anthony Heymann; Irit Lubitz; Itzik Cooper; Efrat Kravitz; Mary Sano; Allen D Roses; Jeremy M Silverman; Ann M Saunders; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-06-13       Impact factor: 4.600

Review 6.  The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.

Authors:  Michael L Alosco; John Gunstad
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

7.  High-Normal Adolescent Fasting Plasma Glucose Is Associated With Poorer Midlife Brain Health: Bogalusa Heart Study.

Authors:  Owen Carmichael; Patrick Stuchlik; Sreekrishna Pillai; Geert-Jan Biessels; Ram Dhullipudi; Anna Madden-Rusnak; Shane Martin; Daniel S Hsia; Vivian Fonseca; Lydia Bazzano
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

8.  Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions.

Authors:  Christine M Burns; Kewei Chen; Alfred W Kaszniak; Wendy Lee; Gene E Alexander; Daniel Bandy; Adam S Fleisher; Richard J Caselli; Eric M Reiman
Journal:  Neurology       Date:  2013-03-27       Impact factor: 9.910

9.  Berberine ameliorates rats model of combined Alzheimer's disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress.

Authors:  Wei-Ting Xuan; Han Wang; Peng Zhou; Ting Ye; Hua-Wu Gao; Shu Ye; Jing-Hui Wang; Meng-Lian Chen; Hang Song; Yan Wang; Biao Cai
Journal:  3 Biotech       Date:  2020-07-29       Impact factor: 2.406

10.  Word-stem priming and recognition in type 2 diabetes mellitus, Alzheimer's disease patients and healthy older adults.

Authors:  María Teresa Redondo; José Luís Beltrán-Brotóns; José Manuel Reales; Soledad Ballesteros
Journal:  Exp Brain Res       Date:  2015-08-08       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.